Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist have?
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist has 645 citations in the OpenAlex counts ScholarIQ stores.
When was Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist published?
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist has 2001 year in the ScholarIQ index.
What is the open-access status of Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist?
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist has closed oa status in the ScholarIQ index.
What is the DOI of Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist?
The DOI for Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist is on the source record.
What is the PMID of Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist?
The PMID for Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist is on the source record.
What is the OpenAlex record for Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist?
The OpenAlex for Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist is on the source record.